Cargando…
DYRK1A, a Novel Determinant of the Methionine-Homocysteine Cycle in Different Mouse Models Overexpressing this Down-Syndrome-Associated Kinase
BACKGROUND: Hyperhomocysteinemia, characterized by increased plasma homocysteine level, is associated with an increased risk of atherosclerosis. On the contrary, patients with Down syndrome appear to be protected from the development of atherosclerosis. We previously found a deleterious effect of hy...
Autores principales: | Noll, Christophe, Planque, Chris, Ripoll, Clémentine, Guedj, Fayçal, Diez, Anna, Ducros, Véronique, Belin, Nicole, Duchon, Arnaud, Paul, Jean-Louis, Badel, Anne, de Freminville, Bénédicte, Grattau, Yann, Bléhaut, Henri, Herault, Yann, Janel, Nathalie, Delabar, Jean-Maurice |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760102/ https://www.ncbi.nlm.nih.gov/pubmed/19844572 http://dx.doi.org/10.1371/journal.pone.0007540 |
Ejemplares similares
-
Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models
por: Souchet, Benoit, et al.
Publicado: (2015) -
Molecular Signatures of Cardiac Defects in Down Syndrome Lymphoblastoid Cell Lines Suggest Altered Ciliome and Hedgehog Pathways
por: Ripoll, Clémentine, et al.
Publicado: (2012) -
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
por: Duchon, Arnaud, et al.
Publicado: (2016) -
Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease
por: Janel, N, et al.
Publicado: (2017) -
One-carbon cycle alterations induced by Dyrk1a dosage
por: Delabar, Jean-Maurice, et al.
Publicado: (2014)